GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now becoming a prominent focus in medical research, largely due to its remarkable impact on managing conditions such as type 2 diabetes and weight gain. Recent research have demonstrated that in addition to glucose management, GLP-1 drugs offer promise for cardiovascular well-being and